Ken Griffin Bioventus Inc. Transaction History
Citadel Advisors LLC
- $505 Billion
- Q3 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Bioventus Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 15,300 shares of BVS stock, worth $179,163. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,300
Previous 6,800
125.0%
Holding current value
$179,163
Previous $39,000
366.67%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding BVS
# of Institutions
142Shares Held
45.9MCall Options Held
179KPut Options Held
124K-
Essex Woodlands Management, Inc. The Woodlands, TX13MShares$152 Million44.65% of portfolio
-
Juniper Investment Company, LLC New York, NY6.94MShares$81.3 Million33.68% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.35MShares$50.9 Million3.09% of portfolio
-
Black Rock Inc. New York, NY2.37MShares$27.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.07MShares$24.3 Million0.0% of portfolio
About Bioventus Inc.
- Ticker BVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 61,664,200
- Market Cap $722M
- Description
- Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...